Effect of Alemtuzumab vs. Interferon beta-1a on Brain Atrophy in Patients with Early, Active Relapsing-Remitting Multiple Sclerosis

被引：0
|
作者：
Zivadinov, Robert
Dwyer, Michael
Bergsland, Niels
Hussein, Sara
Durfee, Jackie
Ramasamy, Deepa
Cherneva, Mariya
Willis, Laura
Cox, Jennifer
Kennedy, Cheryl
Margolin, David
Rizzo, Marco
Palmer, Jeffrey
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A388 / A388
页数：1
相关论文
共 50 条
  • [21] Two-year interim analysis of thyroid abnormalities in a trial of alemtuzumab vs. high-dose interferon beta-1a for treatment of relapsing-remitting multiple sclerosis
    Coles, Alasdair J.
    NEUROLOGY, 2007, 68 (12) : A277 - A277
  • [22] The effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis
    Borges, Isabela T.
    Shea, Colin D.
    Ohayon, Joan
    Jones, Blake C.
    Stone, Roger D.
    Ostuni, John
    Shiee, Navid
    McFarland, Henry
    Bielekova, Bibiana
    Reich, Daniel S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2013, 2 (02) : 133 - 140
  • [23] Effect of different dosages of interferon beta-1a in relapsing-remitting MS patients
    Cocco, E
    Marchi, R
    Floris, G
    Mascia, MG
    Lai, M
    Deriu, M
    Sirco, A
    Mamusa, E
    Frau, J
    Marrosu, MG
    MULTIPLE SCLEROSIS, 2005, 11 : S77 - S77
  • [24] PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY
    Gitlin, M.
    Snyder, S.
    Jhaveri, M.
    VALUE IN HEALTH, 2019, 22 : S746 - S746
  • [25] PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SPAIN
    Gitlin, M.
    Snyder, S.
    Jhaveri, M.
    VALUE IN HEALTH, 2019, 22 : S744 - S744
  • [26] Disability Improvement with Alemtuzumab vs. Interferon beta-1a in Relapsing-Remitting Multiple Sclerosis Patients Who Experienced Disease Activity While on Prior Therapy (CARE-MS II)
    Giovannoni, Gavin
    Arnold, Douglas
    Cohen, Jeffrey
    Coles, Alasdair
    Confavreux, Christian
    Fox, Edward
    Hartung, Hans
    Havrdova, Eva
    Selmaj, Krzysztof
    Weiner, Howard
    Twyman, Cary
    Miller, Tamara
    Lake, Stephen
    Margolin, David
    Panzara, Michael
    Compston, Alastair
    NEUROLOGY, 2013, 80
  • [27] Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis
    De Stefano, Nicola
    Curtin, Francois
    Stubinski, Bettina
    Blevins, Gregg
    Drulovic, Jelena
    Issard, Delphine
    Shotekov, Penko
    Gasperini, Claudio
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (07) : 888 - 892
  • [28] Emerging Methods for Evaluating the Effectiveness of Intramuscular Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis
    Foley, John F.
    Barnes, Christopher J.
    Nair, Kavita V.
    JOURNAL OF MANAGED CARE PHARMACY, 2013, 19 (01): : S16 - S23
  • [29] Effects of two different doses of subcutaneous interferon beta-1a treatment on cognition in patients with early relapsing-remitting multiple sclerosis
    Patti, F.
    Amato, M. P.
    Caniatti, L.
    Di Monte, E.
    Ferrazza, P.
    Goretti, B.
    Lo Fermo, S.
    Picconi, O.
    Tola, M. R.
    Trojano, M.
    MULTIPLE SCLEROSIS, 2007, 13 : S56 - S56
  • [30] Brain atrophy in Relapsing-remitting multiple sclerosis patients treated with interferon-beta and atorvastatin (The ARIANNA study)
    Lanzillo, R.
    Quarantelli, M.
    Veria, V.
    Orefice, G.
    Marrosu, M. G.
    Trojano, M.
    Amato, M. P.
    Francia, A. M.
    Florio, C.
    Tedeschi, G.
    Bellantonio, P.
    Annunziata, P.
    Comerci, M.
    Brunetti, A.
    Bonavita, V.
    Alfano, B.
    Marini, S.
    Pozzilli, C.
    Morra, V. Brescia
    Schiavone, V
    Vacchiano, V.
    Vacca, G.
    Cocco, E.
    Sosso, L.
    Patti, F.
    Stecchi
    Provinciali
    Sinisi, L.
    Ardito, B.
    Maimone, D.
    Zorzon, M.
    Grimaldi, L. M.
    Carolei, A.
    Costantino, G.
    Protti, A.
    Bianconi, C.
    Bertolotto, A.
    Motti, L.
    Meola, G.
    Sacco, R.
    Maniscalco, G.
    JOURNAL OF NEUROLOGY, 2014, 261 : S43 - S44
12345